Association of oxytocin receptor (OXTR) gene variants with multiple phenotype domains of autism spectrum disorder by Campbell, Daniel B. et al.
Association of oxytocin receptor (OXTR) gene variants
with multiple phenotype domains of autism spectrum disorder
Daniel B. Campbell & Dibyadeep Datta &
Shaine T. Jones & Evon Batey Lee & James S. Sutcliffe &
Elizabeth A. D. Hammock & Pat Levitt
Received: 21 June 2010 /Accepted: 17 December 2010 /Published online: 6 January 2011
# Springer Science+Business Media, LLC 2010
Abstract Autism spectrum disorder (ASD) is characterized
by core deficits in social behavior, communication, and
behavioral flexibility. Several lines of evidence indicate that
oxytocin, signaling through its receptor (OXTR), is
important in a wide range of social behaviors. In attempts
to determine whether genetic variations in the oxytocin
signaling system contribute to ASD susceptibility, seven
recent reports indicated association of common genetic
polymorphisms in the OXTR gene with ASD. Each
involved relatively small sample sizes (57 to 436 families)
and, where it was examined, failed to identify association of
OXTR polymorphisms with measures of social behavior in
individuals with ASD. We report genetic association
analysis of 25 markers spanning the OXTR locus in 1,238
pedigrees including 2,333 individuals with ASD. Associa-
tion of three markers previously implicated in ASD
susceptibility, rs2268493 (P=0.043), rs1042778 (P=0.037),
and rs7632287 (P=0.016), was observed. Further, these
genetic markers were associated with multiple core ASD
phenotypes, including social domain dysfunction, measured
by standardized instruments used to diagnose and describe
ASD. The data suggest association of OXTR genetic poly-
morphisms with ASD, although the results should be
interpreted with caution because none of the significant
associations would survive appropriate correction for multi-
ple comparisons. However, the current findings of associa-
tion in a large independent cohort are consistent with
previous results, and the biological plausibility of participa-
tion of the oxytocin signaling system in modulating social
disruptions characteristic of ASD, suggest that functional
polymorphisms of OXTR may contribute to ASD risk in a
subset of families.
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Introduction
Autism spectrum disorder (ASD) is characterized by
abnormalities in three domains: social interaction deficits,
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stricted interests. Despite a widely varying clinical presen-
tation, ASD is highly heritable, with studies demonstrating
a concordance rate of 80–95% in monozygotic twins and
0–31% in dizygotic twins (Folstein and Rutter 1977; Ritvo
et al. 1985; Bailey et al. 1995; Le Couteur et al. 1996;
Taniai et al. 2008; Rosenberg et al. 2009). However, genetic
linkage studies have indicated signals for linkage on nearly
every chromosome (International Molecular Genetic Study
of Autism Consortium 1998; Philippe et al. 1999; Barrett et
al. 1999; Risch et al. 1999; International Molecular Genetic
Study of Autism Consortium 2001; Yonan et al. 2003;
Ylisaukko-oja et al. 2006), suggesting that multiple genes
contribute to ASD susceptibility.
The gene encoding the oxytocin receptor, OXTR,i sa
strong functional ASD candidate gene based on its known
role in modulating social behavior (Ebstein et al. 2009;
Hammock and Levitt 2006). Pharmacological and genetic
manipulations have demonstrated a causal role for oxytocin
(OXT) and its receptor (OXTR) in the regulation of
species-typical social behavior. OXT facilitates social
recognition behavior (Ferguson et al. 2000) and modulates
maternal behavior (Pedersen and Prange 1979; Kendrick et
al. 1987). Moreover, OXT signaling facilitates social
preferences between adult monogamous rodents (Williams
et al. 1992; Williams et al. 1994). In humans, there have
been a number of recent studies demonstrating enhanced
functions relevant to social behavior following oxytocin
application in healthy adults (Heinrichs et al. 2003; Kosfeld
et al. 2005; Rimmele et al. 2009; Zak et al. 2007; Domes et
al. 2007a; Domes et al. 2007b; Guastella et al. 2008a;
Guastella et al. 2008b; Hurlemann et al. 2010). Studies
probing the relationship between OXT and ASD have
generated complex findings. Reported reductions in plasma
OXT (Green et al. 2001; Modahl et al. 1998) and increases
in unprocessed OXT peptides (Green et al. 2001) in young
children with ASD are contrasted by measures of higher
baseline levels of serum OXT in young adults with ASD
compared to control subjects (Jansen et al. 2006). Intrave-
nous or intranasal applications of OXT in youth (Guastella
et al. 2010) and adult (Hollander et al. 2007; Hollander et
al. 2003; Andari et al. 2010) cohorts with ASD generally
improved various functions relevant to social behavior.
Genetic analyses of OXTR contribution to ASD risk have
been inconsistent. Most genome-wide linkage analyses did
not find a peak near the OXTR gene on chromosome 3p25
(International Molecular Genetic Study of Autism Consor-
tium 1998; Philippe et al. 1999; Barrett et al. 1999; Risch et
al. 1999; International Molecular Genetic Study of
Autism Consortium 2001). However, one of the largest
linkage studies performed to date, including 314
families, highlighted a linkage peak directly over the OXTR
gene, establishing OXTR as a positional candidate gene
(Ylisaukko-oja et al. 2006). Seven genetic association
studies of OXTR with ASD have been reported, but
consistent association of alleles is lacking. A study of 195
Chinese families indicated association of two markers in the
third intron of OXTR, rs2254298 A allele and rs53576 A
allele (Wu et al. 2005). Three family-based studies failed to
find association of rs2254298 (Liu et al. 2010; Lerer et al.
2008; Wermter et al. 2010) and another study did not find
association of rs53576 (Jacob et al. 2007). However,
evidence for association of the rs2254298 A allele was
found in a Japanese case–control sample (Liu et al. 2010).
In Caucasian families, the opposite allele, the rs2254298 G
allele, was associated with ASD risk in one study (Jacob et
al. 2007) and contributed to a risk haplotype in another
study (Lerer et al. 2008). A third study of Caucasian
families did not test rs2254298 directly, but found associ-
ation of a nearby intron 3 marker, rs2268493 (Yrigollen et
al. 2008). In addition to the evidence for association of
OXTR intron 3 markers, markers near the 3′ untranslated
region (UTR) have also been implicated in ASD risk (Lerer
et al. 2008; Tansey et al. 2010). Lerer et al. (2008)
described association of the 3′ UTR marker rs1042778 G
allele and Tansey et al. (2010) found association of the
intergenic marker rs7632287 with ASD risk. While differ-
ent reports indicate positive association of OXTR markers in
intron 3 and the 3′ UTR, the studies involved small family
cohorts of less than 500 families each, increasing the risk
for spurious associations (Sullivan 2007). Further, in those
studies that included analysis of phenotype data, the OXTR
markers associated with ASD failed to show association
with measures of social behavior in individuals with ASD
(Lerer et al. 2008; Yrigollen et al. 2008).
Given the sound biological and mixed genetic evidence
in favor of OXTR contribution to ASD, we hypothesized
that analysis of a large sample would provide greater power
to detect association of OXTR markers with ASD suscep-
tibility. Here, we report association analysis of 25 genetic
markers spanning OXTR in 1,238 families, including 2,333
individuals with ASD. In addition to analysis of association
with ASD diagnosis, we examined association with
quantitative scores derived from three instruments used to
diagnose and describe autism phenotypes: the Autism
Diagnostic Interview-Revised (ADI-R), the Autism Diag-
nostic Observation Schedule (ADOS), and the Social
Responsiveness Scale (SRS).
Methods and materials
Sample The family-based sample consisted of 5,432 indi-
viduals from 1,238 pedigrees and included 2,333 individ-
uals with ASD (Table 1). The majority of the sample (921
pedigrees) was collected by the Autism Genetics Resource
102 J Neurodevelop Disord (2011) 3:101–112Exchange (AGRE) Consortium. The remaining 317 “non-
AGRE” pedigrees were collected at the University of Iowa,
Stanford University, Tufts University, and Vanderbilt
University. Approximately 91% of the families had more
than one child with ASD (multiplex). The genotyped
sample is 95% Caucasian by self-report. The sample
analyzed here does not overlap any of the previous reports
of genetic association studies for OXTR in ASD (Wu et al.
2005; Liu et al. 2010; Lerer et al. 2008; Wermter et al.
2010; Jacob et al. 2007; Yrigollen et al. 2008; Tansey et al.
2010). Scores on the ADI-R, ADOS, and SRS were
available for 2,000 individuals from AGRE families
(Table 2). All research was approved by the Institutional
Review Boards of Vanderbilt University and the University
of Southern California.
In-house genotyping SNP selection We genotyped nine
markers spanning the 19.2 kb OXTR gene (Table 3). These
included the three intron 3 markers (rs53576, rs2254298,
and rs2268493) and the 3′ UTR marker (rs1042778) with
previous evidence of association with ASD risk (Wu et al.
2005; Lerer et al. 2008; Jacob et al. 2007; Yrigollen et al.
2008). Based on minor allele frequency >0.15, position
within the gene and linkage disequilibrium patterns in the
HapMap “CEU” Caucasian panel, we also genotyped a
promoter SNP (rs401015), two additional intron 3 SNPs
(rs237897 and rs237885), and two additional 3′ UTR
markers (rs6770632 and rs9872310).
In-house SNP genotyping and quality control Genotyping
was performed using TaqMan
™ SNP genotyping assays on
the ABI Prism 7900HT and analyzed with SDS software as
previously described (Campbell et al. 2006; Campbell et al.
2008). SNP Genotyping Assays-On-Demand were obtained
from Applied Biosystems (Foster City, CA). Genotyping
was performed in a 384-well plate format using 3 ng
genomic DNA. Quality control measures included seeding
of each 384-well plate with eight to ten blank negative
control wells and 20–30 duplicated positive control
samples. Automated allele calls were made with SDS Data
Collection software and reviewed by an experienced
operator according to protocol. The overall no-call rate
was <5% for each of the assays. All analyzed markers were
in Hardy–Weinberg equilibrium (HWE; P>0.05).
GWAS genotyping GWAS of the AGRE Consortium sample
was conducted by the Broad Institute on the Affymetrix 5.0
platform, which includes over 500,000 SNPs, and made
available publicly. We downloaded the genotype information
from the AGRE website (www.agre.org). For analysis
purposes, we used Whole-genome Association Study Pipe-
line. We set the marker genotyping efficiency threshold to a
minimum of 95%, the minor allele frequency threshold to a
minimum of 0.05, the Hardy–Weinberg equilibrium thresh-
old to a minimum of 0.01, and the marker Mendelian error
rate to a maximum threshold of 15 errors. Any marker that
did not meet any of the preceding specifications was
removed from all further analyses. In addition, all mono-
morphic markers and all markers composed of only
heterozygous genotypes were removed. Following this
whole-genome quality control, we selected the markers in
the OXTR gene plus 10 kb of flanking region on each side
(a total of 39.2 kb). From the GWAS genotypes, 17 markers
were analyzed. Only the 3′ UTR marker rs1042778 over-
lapped with the markers genotyped in-house. There was
>98% concordance of the 1,980 samples genotyped for
rs1042778 between the in-house TaqMan
™ and GWAS
genotyping platforms.
Definition of linkage disequilibrium (LD) blocks Haplo-
view (version 3.2) was used to assess HWE and to define
Table 1 Description of ASD family sample
Sample Source Genotyped by Number of Samples Number of Pedigrees Number of Individuals with ASD
Non-AGRE In-house 1,285 317 590
AGRE In-house 2,520 545 1,086
In-house total In-house 3,805 862 1,676
AGRE GWAS 3,607 892 1,530
In-house/GWAS overlap Combined −1,980 −516 −873
Combined total Combined 5,432 1,238 2,333
Table 2 Description of genotyped sample with available phenotype
data
ADI-R ADOS SRS
ADI-R total 1,738 1,348 776
ADI-R verbal 1,160 907 548
ADI-R non-verbal 578 441 228
ADOS 1,348 1,363 688
SRS 776 688 1,029
Shown are the number of individuals with complete scores on the
indicated instrument and the number of overlapping individuals with
scores on multiple instruments. The ADI-R scores are provided as
total and stratified by the number of verbal and non-verbal individuals
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randomly selected from each family using a random
number generator to build trios suitable for Haploview
analysis (Campbell et al. 2006; Campbell et al. 2008).
Analysis of association with ASD diagnosis Family-based
single marker and haplotype association analyses were
performed using the family-based association test (FBAT;
(Horvath et al. 2001)) and haplotype-based association test
(HBAT; (Horvath et al. 2004); FBAT version 1.7.2). We
analyzed only empirically determined genotypes. All FBAT
and HBAT analyses were performed using the empirical
variance (“-e” option) because linkage has been reported for
the chromosomal region containing these genes and because
the empirical variance provides a more conservative estimate
of association. FBAT analysis was performed with both the
additive model and the recessive model because significant
association has been reported with each model (Wu et al.
2005; Yrigollen et al. 2008). HBAT was performed only on
defined LD blocks, only with the additive model, and with
minimum haplotype frequency set to 0.01.
Analysis of association with narrow autism diagnosis On
February 23, 2010, the AGRE pedigree file was down-
loaded from the AGRE website (www.agre.org). We
identified 975 individuals from 618 independent families
with narrow autism, defined by clinical diagnosis con-
firmed by both ADI-R and ADOS classification. FBAT and
HBAT analyses were repeated, again using the empirical
variance (“-e”) option, on this smaller sample of individuals
with narrowly defined autism.
Concordance and correlation among phenotype scores On
February 23, 2010, six files were downloaded from the
AGRE website: the phenotype scores on the SRS, the
ADI-R, and each of the four ADOS modules. The total
number of individuals with phenotype scores for each
instrument and the number of individuals with scores on
multiple instruments are present in Table 2. The phenotype
scores downloaded from the AGRE website were converted
directly to phenotype (.phe) files used for FBAT software
analysis. Scores reported here are: (a) quantitative summa-
tion scores from individual items on the ADI-R and ADOS,
(b) binary cutoff scores from the ADI-R and ADOS, (c)
factor scores from a previously published principal compo-
nents analysis (PCA) of the AGRE sample (Frazier et al.
2008), and (d) T scores derived from total score and
subscales of the SRS. For individuals with SRS scores from
Marker Chr3 Location bp from TrxSt Genotyped by Location in OXTR
rs9860869 8,795,740 −9,440 GWAS Promoter
rs75775 8,795,732 −9,432 GWAS Promoter
rs6443206 8,795,075 −8,775 GWAS Promoter
rs401015 8,789,012 −2,712 In-house Promoter
rs6777726 8,788,494 −2,194 GWAS Promoter
rs2301261 8,785,896 404 GWAS Intron 1
rs4686302 8,784,222 2,078 GWAS Exon 3
rs237897 8,783,285 3,015 In-house Intron 3
rs53576 8,779,371 6,929 In-house Intron 3
rs237889 8,777,483 8,817 GWAS Intron 3
rs2254298 8,777,228 9,072 In-house Intron 3
rs2268493 8,775,840 10,460 In-house Intron 3
rs2268492 8,775,672 10,628 GWAS Intron 3
rs2268491 8,775,398 10,902 GWAS Intron 3
rs237888 8,772,095 14,205 GWAS Intron 3
rs2268490 8,772,085 14,215 GWAS Intron 3
rs237887 8,772,042 14,258 GWAS Intron 3
rs11706648 8,771,547 14,753 GWAS Intron 3
rs237885 8,770,543 15,757 In-house Intron 3
rs1042778 8,769,545 16,755 Combined Exon 4—3′ UTR
rs6770632 8,768,724 17,576 In-house Exon 4—3′ UTR
rs9872310 8,768,381 17,919 In-house Exon 4—3′ UTR
rs7632287 8,766,446 19,854 GWAS Intergenic
rs17297803 8,758,207 28,093 GWAS CAV3 Intron 2
rs237875 8,757,406 28,894 GWAS CAV3 Intron 2
Table 3 Description of markers
genotyped
For each marker, the location on
chromosome 3 and the distance
from the transcription start
(TrxSt) site of OXTR are indi-
cated. Also listed is whether the
marker was genotyped by the
Levitt lab in-house using
Taqman assays or by the Broad
Institute using the Affymetrix
5.0 GWAS platform
104 J Neurodevelop Disord (2011) 3:101–112both parent and teacher scales, the SRS T scores were
averaged from all available informants (Constantino et al.
2009). We performed PCA of the AGRE ADI-R scores
(Campbell et al. 2010) and obtained factor structures that
were indistinguishable from those previously reported
(Frazier et al. 2008); therefore, we also report association
analysis of two-factor scores on the ADI-R. Frazier et al.
(2008) report a two-factor solution with high loadings of
seven variables on the first factor (SOC1T_CS, SOC2T_CS,
SOC3T_CS, SOC4T_CS, COM1T_CS, COM4T_CS, and
COM2VTCS) and three variables on the second factor
(COM3VTCS, BEH1T_CS, and BEH2T_CS). Four distinct
modules of the ADOS are administered, depending upon age
and verbal abilities of the subject, and it is not appropriate to
collapse quantitative phenotype scores across the four ADOS
modules. Further, there was not sufficient power in this
sample to compare across ADOS modules as the number of
subjects in each group ranged from 101 to 540 (mean±
standard deviation=347±192; data not shown). Therefore,
we did not analyze quantitative traits on each of the ADOS
modules. However, each ADOS module contains a module-
specific algorithm for determining whether an individual
meets criteria for autism or ASD and reports a binary cutoff
(yes or no) for meeting the criteria for diagnosis. The ADI-R
and ADOS provide categorical variables that define thresh-
olds for ASD diagnosis. The concordance among these
binary categorical variables was determined by calculating
the number of genotyped individuals with matching cate-
gorical scores compared to the total number of individuals
with genotypes. The ADI-R and SRS provide continuous
total scores for each individual that approximate normal
distributions. Correlations among the continuous variables
were calculated using StatView software.
Analysis of association with phenotype scores FBAT
analysis of the phenotype scores was performed using the
empirical variance (“-e” option) with no offset. Phenotype
analysis was restricted to three markers, and all analyses
performed are reported in the “Results” section. FBAT
analysis was used for ADI-R total scores, Frazier factor
combined scores, and SRS total scores, all of which
approach normal distributions in this sample. FBAT was
Fig. 1 Map of chromosome 3p25 near OXTR gene, markers
genotyped, and linkage disequilibrium (LD). The 19.2 kb OXTR gene
includes four exons, the last of which lies just 3.5 kb from exon 3 of
the neighboring CAV3 gene. LD block 5 includes markers from exon 4
of OXTR, the intergenic region, and intron 2 of CAV3. LD is displayed
in D′. LD blocks are defined by the solid spline method
J Neurodevelop Disord (2011) 3:101–112 105also used to analyze cutoff scores on the ADI-R and ADOS,
all of which are binary (yes/no). We did not attempt analysis
of individual questions on the three phenotypic instruments
as the scores on individual items often fail to be normally
distributed. The reported two-sided P values represent only
those with positive association of the indicated allele; the
indicated allele is positively associated with ASD diagnosis
or phenotype.
Corrections for multiple comparisons We report in the text
uncorrected P values. These results should therefore be in-
terpretedwithgreat caution.Noneofthe reportedassociations
would survive Bonferroni correction for the 25 SNPs ana-
lyzed inthisstudy.We note,however, thatthisisanattempt to
find associations consistent with previously reported associ-
ations of common OXTR markers with ASD risk.
Results
Linkage disequilibrium (LD) structure Analysis of LD
structure indicated five LD blocks in the 39 kb that
includes the OXTR gene and 10 kb of flanking sequence
(Fig. 1). One LD block contains considerable overlap with
the neighboring CAV3 gene, which maps 3.5 kb down-
stream of OXTR in a tail-to-tail arrangement. Interpretation
of markers with LD overlap between the OXTR and CAV3
genes must include the possibility that genetic variants in
CAV3 may contribute to ASD risk.
Association of OXTR markers with ASD diagnosis In the
entire data set of 25 markers genotyped in 1,238 families
including 2,333 individuals with ASD, two markers had
significant association with ASD diagnosis (Fig. 2). First,
the 3′ UTR marker rs1042778 G allele was associated with
ASD risk using the FBAT recessive model (P=0.037).
Association of the rs1042778 G allele is consistent with
two previous reports of positive association (Lerer et al.
2008; Jacob et al. 2007) and further implicates a putative
functional variant near the 3′ UTR of OXTR in ASD risk.
Second, the rs7632287 G allele was associated with ASD
using both the recessive (P=0.016) and additive (P=0.016)
models, consistent with the recent report of Tansey et al.
(2010). The rs7632287 marker is intergenic between OXTR
and the neighboring CAV3 gene and shares LD with
markers in both genes. Therefore, association of
rs7632287 suggests the presence of a functional variant
that affects OXTR and/or CAV3. HBAT did not reveal
significant global association of any of the five LD blocks.
Association of OXTR markers with narrow autism diagno-
sis Family-based analysis of the 975 AGRE individuals
with narrow autism (clinical diagnosis confirmed by both
ADI-R and ADOS) revealed association of three markers
(Fig. 3). Both variants that were associated with ASD also
were associated with narrow autism diagnosis. The 3′ UTR
marker rs1042778 G allele was associated with narrow
autism using the recessive model (P=0.041) and the
intergenic rs7632287 G allele was associated with narrow
autism using both the additive model (P=0.031) and the
recessive model (P=0.004). In addition, the OXTR intron 3
marker rs2268493 T allele was associated with narrow
autism diagnosis using the recessive model (P=0.043),
consistent with a previous positive association (Yrigollen et
al. 2008). HBAT analysis did not reveal significant global
association with risk for narrowly defined autism.
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Fig. 2 Association of OXTR markers with ASD diagnosis in the
entire sample of 1,238 families. Markers are numbered as in Fig. 1.
The 3′ UTR marker rs1042778 G allele (marker 20) is associated with
ASD diagnosis by the recessive model (P=0.037). The intergenic
marker rs7632287 (marker 23) G allele is associated with ASD
diagnosis by both the recessive model (P=0.016) and the additive
model (P=0.016)
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Fig. 3 Association of OXTR markers with narrow autism diagnosis in
the AGRE sample. Markers are numbered as in Fig. 1. The OXTR
intron 3 marker rs2268493 (marker 12) T allele was associated with
narrow autism diagnosis using the recessive model (P=0.043). The 3′
UTR marker rs1042778 G allele (marker 20) was associated with
narrow autism using the recessive model (P=0.041). The intergenic
marker rs7632287 (marker 23) G allele was associated with narrow
autism diagnosis using both the recessive model (P=0.004) and the
additive model (P=0.031)
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provide two distinct types of variables. First, the ADI-R and
ADOS provide categorical variables that define binary
(yes/no) thresholds for diagnosis or a phenotype domain
cutoff. In our sample, the concordance (rate of agreement
on an individual eclipsing the threshold) among the 15
categorical variables was high, ranging from 0.732 to 1.000
(Table 4). High concordance rates among these categorical
variablesshouldbeexpectedforasampleselectedforanASD
diagnosis. Second, the ADI-R and SRS provide continuous
total scores that give a more complete description of the
phenotype domains. In our sample, the correlation among
these continuous variables ranges from 0.012 to 0.983, with
some correlations being negative (Table 5). The broad range
of correlations among the continuous variables reflects the
phenotypic heterogeneity of ASD.
Analysis of phenotype data The number of individuals with
available phenotype data with each of the three instruments
for measurement of ASD traits is detailed in Table 2.
Phenotype analysis was restricted to the three OXTR
markers that showed significant association with ASD and
narrow autism risk: intron 3 marker rs2268493, 3′ UTR
marker rs1042778, and intergenic marker rs7632287.
Table 6 describes association of these OXTR markers with
categorical variables measured on the ADI-R and ADOS.
Table 7 describes association of the three OXTR markers
with continuous variables on the ADI-R and SRS.
Association of a genetic marker with two highly correlated
phenotype measures may reflect an inability to dissect the
phenotypes, rather than a contribution of the genetic variant
to each phenotype independently.
Association of OXTR markers with categorical cutoff scores
on the ADI-R and ADOS The intron 3 marker rs2268493 T
allele was associated with 14 of the 15 categorical cutoff
scores on the ADI-R and ADOS using the FBAT recessive
model (Table 6). Using the FBAT additive model, the intron
3 marker rs2268493 T allele was associated only with the
non-verbal communication cutoff (Table 6). The 3′ UTR
marker rs1042778 G allele was not associated with any
cutoff on the ADI-R (Table 6), but was associated with
autism diagnosis (P=0.013), ASD diagnosis (P=0.043),
autism social cutoff (P=0.036), and the autism communi-
cation plus social cutoff (P=0.021) on the ADOS using the
FBAT recessive model. The intergenic marker rs7632287 G
allele was associated with 14 of 15 categorical cutoff scores
on the ADI-R and ADOS (Table 6). In contrast to the intron
3 marker rs2268493 T allele, the association of the
intergenic marker rs7632287 G allele was independent of
FBAT model used (Table 6). The only categorical variable
with which the rs7632287 G allele was not significantly
associated was the non-verbal communication cutoff
(Table 6), the phenotype measure with the least power in
our sample (Table 2).
Association of OXTR markers with continuous scores on
the ADI-R and SRS The intron 3 marker rs2268493 T allele
was associated with the social total score (P=0.011), the
non-verbal communication total score (P=0.026), the
development total score (P=0.022), and Frazier Factor 1
(P=0.011) using the FBAT recessive model (Table 7). The
3′ UTR marker rs1042778 G allele was not associated with
any continuous variable score (Table 7). The rs7632287 G
allele was associated with 12 of 14 continuous phenotype
scores (Table 7). The rs7632287 G allele was associated
with the social total (P=0.022), the verbal communication
total (P=0.010), the behavior total (P=0.002), the devel-
opment total (P=0.029), Frazier Factor 1 (P=0.018), and
Frazier Factor 2 (P=0.001) on the ADI-R using the FBAT
recessive model (Table 7). Consistent with the categorical
cutoff scores for the ADI-R, the rs7632287 G allele was not
associated with the non-verbal communication total or the
communication total scores on the ADI-R (Table 7) but was
associated with the other six variables independent of the
FBAT model used (Table 7). The rs7632287 G allele was
associated with the SRS total score (P=0.029) and each of
the SRS sub-scale scores using the FBAT recessive model
(Table 7).
Discussion
The present study represents the largest family-based analysis
to date of association of common OXTR genetic variants with
ASD risk. As in previous reports of genetic association for
OXTR, we found evidence of association in two distinct
regions of the gene: intron 3 and the 3′ UTR. Associations of
markers in intron 3 implicate the OXTR gene specifically in
ASD susceptibility. The genetic associations in the 3′ UTR
region, however, could influence either OXTR or CAV3
because the LD block overlaps regions of both genes. Our
results are consistent with (Sullivan 2007)p r e v i o u sr e p o r t s
of association of the intron 3 marker rs2268493, the 3′ UTR
marker rs1042778, and the intergenic marker rs7632287.
These data also indicate, for the first time, association of
OXTR genetic polymorphisms with social aspects of ASD.
None of the reported nominally significant associations
would survive appropriate correction for multiple compar-
isons, so these data should be interpreted cautiously.
However, the additional suggestive evidence in support of
previous genetic association data from smaller, independent
family cohorts, as well as the biological plausibility, suggest
that polymorphisms of OXTR may contribute to ASD risk in
subsets of families that may exhibit other unique features
J Neurodevelop Disord (2011) 3:101–112 107T
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108 J Neurodevelop Disord (2011) 3:101–112that correlate with this risk gene (Sullivan 2007; Lucht et al.
2009). The additional genetic evidence highlights two
specific regions, intron 3 and the 3′ UTR, of OXTR that
warrant further research.
Three recent genome-wide association studies have each
identified genome-wide significant association signals at
single loci on chromosomes 5p14.1 (Wang et al. 2009),
5p15 (Weiss et al. 2009), and 20p13 (Anney et al. 2010).
Table 5 Correlation (r) of continuous variables
ADI-R SRS
Verbal
Comm
Non-verbal
Comm
Beh Dev Frazier
Factor 1
Frazier
Factor 2
Aware Cog Comm Motiv Manner Total
ADI-R Social 0.727 0.564 0.304 0.407 0.958 0.014 0.471 0.452 0.492 0.441 0.426 0.502
ADI-R Verbal
Comm
No Overlap 0.420 0.353 0.860 0.497 0.359 0.409 0.400 0.344 0.375 0.420
ADI-R Non-
verbal Comm
0.144 0.106 0.751 0.056 0.303 0.224 0.267 0.177 0.183 0.253
ADI-R Beh 0.087 0.314 0.502 0.167 0.196 0.169 0.173 0.246 0.208
ADI-R Dev 0.417 −0.175 0.196 0.200 0.200 0.150 0.162 0.199
ADI-R Frazier
Factor 1
0.070 0.454 0.455 0.484 0.423 0.416 0.492
ADI-R Frazier
Factor 2
−0.132 0.012 −0.045 −0.007 0.013 −0.020
SRS Aware 0.867 0.896 0.758 0.845 0.915
SRS Cog 0.934 0.831 0.891 0.962
SRS Comm 0.849 0.912 0.983
SRS Motiv 0.788 0.891
SRS Manner 0.946
Continuous variables are those with a range of possible scores
ADI-R Autism Diagnostic Interview-Revised, SRS Social Responsiveness Scale, Comm communication, Beh behavior, Dev development, Aware
awareness, Cog cognition, Motiv motivation, Manner mannerisms
Table 6 Association of OXTR markers with categorical phenotype cutoff scores on the ADI-R and ADOS (P values)
rs2268493 T allele rs1042778 G allele rs7632287 G allele
Additive
model
Recessive
model
Additive
model
Recessive
model
Additive
model
Recessive
model
ADI-R
Autism 0.034 0.043 0.014
Social 0.025 0.034 0.021
Verbal Comm 0.047 0.030
Non-verbal Comm 0.012 0.033
Comm 0.025 0.038 0.033
Behavior 0.036 0.037 0.022
Development 0.043 0.019 0.019
ADOS
Autism diagnosis 0.022 0.048 0.013 0.040 0.006
ASD diagnosis 0.037 0.043 0.021 0.007
Autism Comm Cutoff 0.037 0.054 0.010
ASD Comm Cutoff 0.038 0.030 0.011
Autism Social Cutoff 0.025 0.036 0.019 0.004
ASD Social Cutoff 0.021 0.013 0.004
Autism Comm+Social
Cutoff
0.032 0.021 0.028 0.005
ASD Comm+Social Cutoff 0.033 0.023 0.008
J Neurodevelop Disord (2011) 3:101–112 109The functional significance of these findings is yet to be
determined. Although none of the genome-wide association
studies highlighted the OXTR gene at chromosome 3p25,
two described suggestive evidence for association of OXTR
markers. Wang et al. (2009) described association of OXTR
marker rs75775 (P=0.003) and Anney et al. (2010)
described association of OXTR marker rs2301261 (P=
0.016). Neither of these markers showed nominally
significant association in our analyses (Fig. 2; rs75775:
marker 2, P=0.677; rs2301261: marker 6, P=0.926).
Similarly, although genome-wide copy number variation
analyses have not highlighted OXTR (Glessner et al. 2009),
a recent report described deletion of the region including
OXTR, CAV3, and three neighboring genes in a single
proband in one of 119 families (Gregory et al. 2009). The
same report also described altered patterns of methylation
in the OXTR promoter in individuals with ASD and a
decreased expression of OXTR in postmortem brains of
individuals with ASD (Gregory et al. 2009). Therefore,
there may be multiple modes of disrupting OXTR that result
in decreased expression of the oxytocin receptor and an
increased risk for ASD.
A bioinformatics analysis indicated that the G allele of
rs7632287 may alter transcription factor binding. Consite
(http://asp.ii.uib.no:8090/cgi-bin/CONSITE/consite/)p r e -
dicts that COUP-TF is the only transcription factor that
will bind the A allele but that the G allele will also be
bound by the N-MYC, ARNT, and USF transcription
factors. Experimental evidence will be necessary to deter-
mine if any of these transcription factors alter expression. A
meta-analysis of OXTR association in all published data
will provide a definitive answer to the association of
common variants in OXTR with ASD. Our data set is
publicly available at www.agre.org.
Our data suggest that the rs7632287 variant contributes
to multiple domains of ASD. It should be expected that a
genetic marker associated with one phenotype score will
also be associated with a second highly correlated pheno-
type score. However, the rs7632287 G allele was associated
with both Frazier Factor 1 and Frazier Factor 2 scores, even
though these two phenotypic variables are only 0.070
correlated. Similarly, the rs7632287 G allele was associated
with both ADI-R development total score and the SRS total
score, despite the two variables being only 0.199 correlated.
These data suggest that, rather than association due to
highly correlated scores, the rs7632287 G allele is
associated with each phenotypic domain. We were some-
what surprised by the data indicating that all domains of
autism were correlated with genotype, rather than the
expected statistical enrichment for OXTR relationship with
specific social endophenotypes. One possible explanation
for this broad association may lie in the robust develop-
mental expression of OXTR in many more brain areas than
in the adult (Shapiro and Insel 1989; Snijdewint et al. 1989;
Wang et al. 1997). Thus, there could be an early role for
OXT in developing neural circuitry that underlies behaviors
beyond those of social interactions. As has been reported
for many genes, early perturbation can lead to later onset
brain dysfunctions that would not be reflected in adult
expression patterns (Thompson and Levitt 2010). This also
Table 7 Association of OXTR markers with continuous phenotype scores on the ADI-R and SRS (P values)
rs2268493 T allele rs1042778 G allele rs7632287 G allele
Additive model Recessive model Additive model Recessive model Additive model Recessive model
ADI-R
Social Total 0.038 0.011 0.037 0.022
Verbal Comm Total 0.022 0.010
Non-verbal Comm Total 0.010 0.026
Comm Total
Behavior Total 0.008 0.002
Development Total 0.022 0.029 0.029
Frazier Factor 1 0.046 0.011 0.029 0.018
Frazier Factor 2 0.003 0.001
SRS
SRS total 0.029
Social awareness 0.025
Social cognition 0.025
Social communication 0.028
Social motivation 0.035
Autistic mannerisms 0.046 0.037
110 J Neurodevelop Disord (2011) 3:101–112suggests that the broader functions influenced through
developmental mechanisms would not be captured by
intranasal OXT in healthy adults, in which functions
associated with social domains show improvement. Rele-
vant to the present study, the more widespread develop-
mental expression of OXTR may contribute to broad
domains of social phenotypes, underlying the broad
association of OXTR genotypes with behavioral traits in
ASD. Our data also suggest that clinical trials with OXT in
young children should examine functional domains beyond
those related to social behavior.
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